发明名称 |
Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity |
摘要 |
Described herein are antimicrobial peptides for use in pharmaceutical antibiotic compositions and methods of use thereof. These antimicrobial peptides are Gramicidin A (gA) peptide analogs that, in addition to having potent anti-microbial activity, have greatly increased solubility and significantly reduced toxicity in comparison to the wild-type Gramicidin A peptide. |
申请公布号 |
US9243037(B2) |
申请公布日期 |
2016.01.26 |
申请号 |
US201214357084 |
申请日期 |
2012.11.09 |
申请人 |
Trustees of Boston College |
发明人 |
Gao Jianmin;Wang Fang |
分类号 |
A01N37/18;A61K38/00;A61P31/04;C07K7/28;A61K38/10;A01N43/38 |
主分类号 |
A01N37/18 |
代理机构 |
Nixon Peabody LLP |
代理人 |
Nixon Peabody LLP ;Eisenstein Ronald I.;Karttunen Contarino Leena H. |
主权项 |
1. An anti-microbial composition comprising at least one Gramicidin A peptide analog or derivative having reduced cytotoxicity and increased solubility relative to wild-type Gramicidin A wherein the wild-type Gramicidin A comprises the amino acid sequence of SEQ ID NO: 2, and wherein the at least one Gramicidin A peptide analog or derivative comprises the amino acid sequence of SEQ ID NO: 2, wherein one of the d-Leucine amino acids at positions 10 or 14 of the SEQ ID NO: 2 have been replaced or substituted with a cationic residue. |
地址 |
Chestnut Hill MA US |